ijms-logo

Journal Browser

Journal Browser

New Advances in Congenital Disorders—From Molecular Basis

A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Pathology, Diagnostics, and Therapeutics".

Deadline for manuscript submissions: 15 May 2024 | Viewed by 496

Special Issue Editors


E-Mail Website
Guest Editor
Congenital Disorders of Glycosylation & Allies—Professionals and Patient Associations International Network (CDG & Allies-PPAIN), Department of Life Sciences, School of Science and Technology, NOVA University Lisbon, 2819-516 Caparica, Portugal
Interests: congenital disorders; neurological disorders; rare diseases; medical writing

E-Mail Website
Guest Editor
Department of Clinical Genetics, Erasmus MC Rotterdam, 3000 CA Rotterdam, The Netherlands
Interests: uveal melanoma; retinal capillary hemangioblastoma; Barrett esophagus and esophageal cancer; translational genetics; metabolomics; transcriptomics
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

Congenital disorders, also known as birth defects, can contribute to long-term disability, having profound impacts on patients, families, healthcare systems, and society. According to the World Health Organization, 240 000 newborns die every year within 28 days after birth, representing a considerable public health burden. Congenital disorders may be caused by genetic, nutritional, environmental, or infectious factors, but their etiology remains to be fully understood. Inevitably, the high heterogeneity of and unclear pathomolecular mechanisms beyond these genetic disorders give rise to a complex and challenging patient journey until a final diagnosis is achieved. Noteworthily, in recent years the advances in multi-omics techniques and high-throughput methodologies contributed to increasing data generation, paving the way for the successful development of novel biomarkers, the discovery of new diagnosis methods, and novel targeted therapies.

The main goal of this Special Issue, entitled “New Advances in Congenital Disorders – from Molecular Basis”, is to bring together new research by collecting original articles and reviews that provide novel insights related to genetics, diagnosis, biomarkers, mechanisms, and therapeutics related to birth defects.

Dr. Joana Poejo
Dr. Erwin Brosens
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • congenital disorders
  • birth defects
  • genetic diseases
  • biomarker discovery
  • diagnosis
  • development of therapeutics molecular mechanisms

Published Papers

This special issue is now open for submission.
Back to TopTop